Distinct consequences of posttranslational modification by linear versus K63-linked polyubiquitin chains.
Polyubiquitin chains mediate a variety of biological processes, ranging from proteasomal targeting to inflammatory signaling and DNA repair. Their functional diversity is in part due to their ability to adopt distinct conformations, depending on how the ubiquitin moieties within the chain are linked. We have used the eukaryotic replication clamp PCNA, a natural target of lysine (K)63-linked polyubiquitylation, as a model substrate to directly compare the consequences of modification by different types of polyubiquitin chains. We show here that K63-polyubiquitylated PCNA is not subject to proteasomal degradation. In contrast, linear, noncleavable ubiquitin chains do not promote DNA damage tolerance, but function as general degradation signals. We find that a linear tetraubiquitin chain is sufficient to afford proteasomal targeting through the Cdc48-Npl4-Ufd1 complex without further modification. Although a minimum chain length of four is required for degradation, a longer chain does not further reduce the half-life of the respective substrate protein. Our results suggest that the cellular machinery responsible for recognition of ubiquitylated substrates can make subtle distinctions between highly similar forms of the polyubiquitin signal.
Zhao
Shengkai
S
Cancer Research UK London Research Institute, Clare Hall Laboratories, Blanche Lane, South Mimms EN6 3LD, United Kingdom.
Ulrich
Helle D
HD
D015152:Blotting, Northern; D015153:Blotting, Western; D004249:DNA Damage / Q000502:physiology; D025821:Polyubiquitin / Q000378:metabolism*; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism*; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D011499:Protein Processing, Post-Translational / Q000502:physiology*; D012441:Saccharomyces cerevisiae; D015398:Signal Transduction / Q000502:physiology*
D018809:Proliferating Cell Nuclear Antigen; D025821:Polyubiquitin; D046988:Proteasome Endopeptidase Complex
Mol Cell. 2008 Mar 14;29(5):625-36
18342608
Nature. 2002 Sep 26;419(6905):403-7
12353037
Genes Genet Syst. 2004 Apr;79(2):77-86
15215673
J Mol Biol. 2007 May 4;368(3):753-66
17368669
Science. 1989 Mar 24;243(4898):1576-83
2538923
Nat Struct Mol Biol. 2005 Aug;12(8):708-14
16007098
Nat Cell Biol. 2006 Jul;8(7):700-10
16799550
Cell. 2009 Mar 20;136(6):1098-109
19303852
Nature. 2003 Sep 11;425(6954):188-91
12968183
EMBO J. 2009 Dec 2;28(23):3657-66
19851286
EMBO J. 2006 Oct 18;25(20):4877-87
17006537
Genes Dev. 1988 Jun;2(6):707-17
3138162
EMBO J. 2009 Feb 18;28(4):359-71
19153599
Cell. 1999 Mar 5;96(5):635-44
10089879
Biochem Biophys Res Commun. 2004 Jul 30;320(3):840-5
15240124
Mol Cell. 2009 Feb 13;33(3):275-86
19217402
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15954-9
16247017
J Biol Chem. 2001 Jul 27;276(30):27936-43
11369780
EMBO J. 1992 Feb;11(2):497-505
1311250
Mol Cancer Ther. 2004 Oct;3(10):1263-9
15486193
DNA Repair (Amst). 2009 Apr 5;8(4):461-9
19217833
Science. 1986 Oct 10;234(4773):179-86
3018930
Bioessays. 2000 May;22(5):442-51
10797484
J Biol Chem. 1995 Apr 7;270(14):8172-8
7713922
Nucleic Acids Res. 2007;35(3):881-9
17251197
Cell. 2005 Jan 14;120(1):73-84
15652483
Mol Cell. 2005 Jul 1;19(1):123-33
15989970
J Mol Biol. 2008 Feb 8;376(1):221-31
18155241
J Biol Chem. 1995 Jul 21;270(29):17442-56
7615550
Nature. 2002 Sep 12;419(6903):135-41
12226657
Nat Struct Mol Biol. 2009 Dec;16(12):1328-30
19935683
EMBO Rep. 2008 Jun;9(6):536-42
18516089
Science. 2002 Oct 18;298(5593):611-5
12183636
Nat Chem Biol. 2009 Jan;5(1):29-36
19029916
EMBO Rep. 2009 May;10(5):466-73
19373254
Nat Cell Biol. 2006 Apr;8(4):339-47
16531995
Cell. 2009 Apr 3;137(1):133-45
19345192
Mol Cell. 2004 May 21;14(4):491-500
15149598
Nat Biotechnol. 2000 Dec;18(12):1298-302
11101811
Nat Cell Biol. 2009 Feb;11(2):123-32
19136968
Mutat Res. 2006 Jan 29;593(1-2):153-63
16095633
EMBO J. 2000 Jan 4;19(1):94-102
10619848
Mol Microbiol. 2003 Sep;49(5):1321-32
12940990
Cell. 2000 Oct 13;103(2):351-61
11057907